Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Director Saiyed Atiq Raza of Arteris , Inc. (NASDAQ:AIP), a $400 million market cap company, sold 19,809 shares of common stock on June 27, 2025, according to a recent SEC Form 4 filing. The shares were sold at a weighted average price of $10.0203, resulting in a total transaction value of $198,492. According to InvestingPro data, the stock has delivered a 25% return over the past year, despite recent market volatility.
The sales were executed in multiple transactions at prices ranging from $10.00 to $10.10. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on June 6, 2024.
Following the transaction, Raza indirectly holds 683,798 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Raza serves as trustee. Additionally, Raza directly holds 20,839 shares of Arteris, Inc.
Paul Alpern, as Attorney-in-Fact, signed the Form 4 on behalf of S. Atiq Raza on July 1, 2025.
In other recent news, Arteris Inc. reported a 28% increase in revenue for Q1 2025, reaching $16.5 million, surpassing the forecasted $15.69 million. This growth was largely driven by AI-related deals, which now constitute over 55% of Arteris’ business. Additionally, the company achieved a record annual contract value plus royalties of $66.8 million, marking a 15% year-over-year increase. Arteris also reported a positive free cash flow of $2.7 million for the quarter. In a separate development, Arteris conducted its annual stockholder meeting, where K. Charles Janac and S. Atiq Raza were elected as Class I directors, and Deloitte & Touche, LLP was ratified as the independent accounting firm for the fiscal year ending December 31, 2025. The company also announced its participation in the Intel (NASDAQ:INTC) Foundry Accelerator Program, which is expected to enhance its role in the semiconductor ecosystem. Despite economic uncertainties, Arteris remains optimistic about its growth trajectory, particularly in the AI and automotive sectors. Analyst firms such as TD Cowen and Rosenblatt Securities engaged with Arteris during the earnings call, highlighting the company’s strategic focus and robust pipeline.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.